The Impact of Adherence and Development of Neutralizing Antibodies to Interferons β on Treatment of Multiple Sclerosis in the Czech Republic. Kruntoradova K, Klimes J, Dolezal T, Mandelikova M, Pavlikova P Value Health. 2014 Nov; 17(7):A397. PMID: 27200935. Abstract CommentRecommendBookmarkWatch